Sample size formulae for trials comparing group and individual treatments in a multilevel model

Statistics in Medicine

Volumn 27, Issue 15, 2008, Pages 2850-2864

  Moerbeek, Miriam ^a   Wong, Weng Kee ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cost function; Group therapy; Intra class correlation coefficient; Multilevel model; Power

Indexed keywords

ANALGESIC AGENT;

ABSENTEEISM; ALLOPATHY; ARTICLE; BAYES THEOREM; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COUNSELING; GROUP THERAPY; HUMAN; INTERMETHOD COMPARISON; MALE; MUSCULOSKELETAL PAIN; PHYSIOTHERAPY; PROSTATE CANCER; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SCREENING TEST; STANDARDIZATION; TREATMENT OUTCOME;

ABSENTEEISM; BAYES THEOREM; CLINICAL TRIALS AS TOPIC; HUMANS; MODELS, STATISTICAL; NORWAY; PAIN; PSYCHOTHERAPY, GROUP; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 47249159546     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3115     Document Type: Article

References (39)

1. Lee CJ, Thompson SG. The use of random effects models to allow for clustering in individually randomized trials. Clinical Trials 2005; 2(2):163-173.
2. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Erlbaum: Hillsdale, NJ, 1988.
3. Schouten HJA. Sample size formula with a continuous outcome for unequal group sizes and unequal variances. Statistics in Medicine 1999; 18(1):87-91.
4. Chow SC, Shao J, Wang H. Sample Size Calculations in Clinical Research. Marcel Dekker Inc.: New York, 2003.
5. Dette H. On robust and efficient design for risk estimation in epidemiological studies. Scandinavian Journal of Statistics 2004; 31(3):319-331.
6. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. Arnold Publishers: London, 2000.
7. Murray DM. Design and Analysis of Group-randomized Trials. Oxford University Press: New York, 1998.
8. Liu XF. Statistical power and optimum sample allocation ratio for treatment and control having unequal costs per unit of randomization. Journal of Educational and Behavioral Statistics 2003; 28(3):231-248.
9. Moerbeek M, Van Breukelen GJP, Berger MPF. Design issues for experiments in multilevel populations. Journal of Educational and Behavioral Statistics 2000; 25(3):271-284.
10. Moerbeek M, Van Breukelen GJP, Berger MPF. Optimal experimental designs for multilevel logistic models. The Statistician 2001; 50(1):17-30.
11. Raudenbush SW. Statistical analysis and optimal design for cluster randomized trials. Psychological Methods 1997; 2(2):173-185.
12. Schnurr PP, Friedman MJ, Lavori PW, Hsieh FY. Design of Department of Vetarans Affairs Cooperative Study No. 420: group treatment of posttraumatic stress disorder. Controlled Clinical Trials 2001; 22(1):74-88.
13. Crits-Christoph P, Mintz J. Implications of therapist effects for the design and analysis of comparative studies of psychotherapies. Journal of Consulting and Clinical Psychology 1991; 59(1):20-26.
14. Martindale C. The therapist as fixed effect fallacy in psychotherapy research. Journal of Consulting and Clinical Psychology 1978; 46(6): 1526-1530.
15. Myers JL, DiCecco JV, Lorch RF. Group dynamics and individual performance. Journal of Personality and Social Psychology 1981; 40(1):86-98.
16. Kenny DA, Judd CM. Consequences of violating independence assumptions in analysis of variance. Psychological Bulletin 1986; 99(3):422-431.
17. Kenny DA, Mannetti L, Pierro A, Livi S, Kashy DA. The statistical analysis of data from small groups. Journal of Personality and Social Psychology2002; 83(1):126-137.
18. Roberts C. The implications of variation in outcome between health professionals for the design and analysis of randomized controlled trials. Statistics in Medicine 1999; 18(19):2605-2615.
19. Otto MW, Pollack MH, Gould RA, Wothington JJ, McArdle ET, Rosenbaum JF. A comparison of the efficacy of Clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. Journal of Anxiety Disorders 2000; 14(4):345-358.
20. Pisinger C, Vestbo J, Borch-Johnsen K, Jørgensen T. Smoking cessation intervention in a large randomised population-based study. The Inter99 study. Preventive Medicine 2005; 40(3):285-292.
21. Roberts C, Roberts SA. The design and analysis of clinical trials with clustering effects due to treatment. Clinical Trials 2005; 2(2):152-162.
22. Goldstein H. Multilevel Statistical Models (3rd edn). Edward Arnold: London, 2003.
23. Hox JJ. Multilevel Analysis. Techniques and Applications. Erlbaum: New Jersey, 2002.
24. Snijders TAB, Bosker RJ. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. Sage: London, 1999.
25. Rasbash J, Steele F, Browne B. A User's Guide to MLwiN Version 2.0. Institute of Educations: London, 2004.
26. Hoover DR. Clinical trials of behavioral interventions with heterogeneous teaching subgroup effects. Statistics in Medicine 2002; 21(10):1351-1364.
27. Cohen JA. A power primer. Psychological Bulletin 1992; 112(1):155-159.
28. Dumville JC, Hahn S, Miles JNV, Torgerson DJ. The use of unequal randomisation ratios in clinical trials: a review. Contemporary Clinical Trials 2006; 27(1):1-12.
29. Haugli L, Steen E, Lærum E, Nygard R, Finset A. Learning to have less pain - is it possible? A one-year follow-up study of the effects of a personal construct group learning programme on subjects with chronic musculoskeletal pain. Patient Education and Counseling 1999; 45(2): 111-118.
30. Chaloner K, Church T, Matts JP, Louis TA. Graphical elicitation of a prior distribution for a clinical trial. The Statistician 1993; 42:341-353.
31. Chaloner K, Rhame FS. Quantifying and documenting prior beliefs in clinical trials. Statistics in Medicine 2001; 20:581-600.
32. Tsai C, Chaloner K. Using prior opinions to examine sample size in a clinical trial: two examples. In Case Studies in Bayesian Statistics 5, Kass RE et al. (eds). Springer: New York, 2002; 409-423.
33. Spiegelhalter D, Thomas A, Best N, Lunn D. WinBUGS Version 1.4 User Manual. MRC Biostatistics Unit: Cambridge, 2003.
34. Insightful Corporation. S-PLUS 6 for WINDOWS User's Guide. Insightful Corporation: Seattle, 2001.
35. Kerry SM, Bland JM. Unequal cluster sizes for trials in English and Welsh general practice: implications for sample size calculations. Statistics in Medicine 2001; 20(3):377-390.
36. Van Breukelen GJP, Candel MJJM, Berger MPF. Relative efficiency of unequal versus equal cluster sizes in cluster randomized and multicentre trials. Statistics in Medicine 2007; 26(13):2589-2603.
37. Spiegelhalter DJ. Bayesian methods for cluster randomized trials with continuous responses. Statistics in Medicine 2001; 20(3):435-452.
38. Turner RM Thompson SG, Spiegelhalter DJ. Prior distributions for the intracluster correlation coefficient, based on multiple previous estimates, and their application in cluster randomized trials. Clinical Trials 2005; 2(2):108-118.
39. Lake S, Kammann E, Klar K, Betensky RA. Sample size re-estimation in cluster randomization trials. Statistics in Medicine 2002; 21(10):1337-1350.